|
|
![Public Health Agency of Canada (PHAC)](../../../gfx_common/pphb.gif)
Announcement
Announcement
Formation of the Canadian Prostate Cancer Research Initiative
The Canadian Prostate Cancer Research Initiative (CPCRI) has been
formed in direct response to recommendations from the National Forum
on Prostate Cancer in 1997. The CPCRI is an alliance among Health
Canada, the National Cancer Institute of Canada, the Canadian Cancer
Society and the Canadian Prostate Cancer Network. Its purpose is to
strengthen existing capacities and stimulate new efforts across Canada
in prostate cancer research, with an emphasis on strategic initiatives
to fill gaps, build capacity in important research areas and to respond
to unique opportunities.
The Board of Directors, representing the founding partners, will provide
governance and strategic direction and will seek additional funding
sources for prostate cancer research. The Management Committee will
direct the Initiative's research programs by establishing research
priorities and policies, overseeing the scientific review process,
making research funding recommendations and raising awareness of issues
surrounding prostate cancer research.
The Management Committee includes community representatives and expertise
from the range of professional disciplines involved in prostate cancer
research (laboratory science, radiation oncology, surgical oncology,
medical oncology, epidemiology, behavioural science and health policy).
Current members are George E Connell (Chair), Marvin Brodsky, Lorna
Butler, Yves Fradet, Mary Gospodarowicz, Charles Hollenberg, Robert
Kerbel, François Meyer, Peter M Venner, George Richards and
David Brittain.
For information about the CPCRI, please contact Gareth Taylor
at (416) 934-5656. |
[Previous][Table
of Contents [Next]
|